Understanding the Impact of Market Maturity and Accessing RWD Globally

Monday 30 January, 2PM-3PM GMT

 


 

 

 
 

As the real world data market is maturing, a global paradigm change in generation, collection and analysis of large amounts of health data, is taking place. Research access to RWD has become a key pillar in overall healthcare development, both in clinical care and in drug development. This panel will discuss the importance of technology readiness, local expertise, government investment and regulatory clarity in the context of global data access, and present the state of RWD sharing readiness in their respective countries.

 
Speakers:
Nino da Silva , Chief Commercial Officer Global Sales and Deputy Managing Director, BC Platforms (Moderator)
Prof. Tõnu Esko , Prof. in Human Genomics, Institute of Genomics, and Chief Scientist, Science Accelerator for Health Technologies,
University of Tartu, Estonia
Prof. Collen Masimirembwa , President and Chief Scientific Officer, African Institute of Biomedical Science & Technology (AiBST),
Wilkins Hospital, Zimbabwe and Chief Medical Officer, African Institute of Everyone Genome (AiEG)
Assoc. Prof. Teeradache Viangteeravat , Director of R&D, Bumrungrad International Hospital, Thailand
 
 
 

Get involved at BioTechX

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com

 

Danielle Thomas
danielle.thomas@terrapinn.com

 

TO SPEAK


Joanna Magaji
joanna.magaji@terrapinn.com

 

Taira Marshall
taira.marshall@terrapinn.com

 

MARKETING OPPORTUNITIES


Diana Cobzac
diana.cobzac@terrapinn.com